Zinc oxide
RTECS #
ZH4810000
CAS #
Updated
December 2018
Molecular Weight
81.37
Molecular Formula
OZn
Synonyms
Actox 14
Actox 16
Actox 216
AI3-00277
Akro-zinc bar 85
Akro-zinc bar 90
Amalox
Azo-33
Azo-55
Azo-55TT
Azo-66
Azo-66TT
Azo-77
Azo-77TT
Azodox-55
Azodox-55TT
C.I. 77947
C.I. Pigment White 4
Cadox XX 78
Chinese White
Cynku tlenek (Polish)
Electox 2500
Emanay zinc oxide
EMAR
Felling zinc oxide
Flowers of zinc
GIAP 10
Green seal-8
Hubbuck's White
Kadox 15
Kadox 72
Kadox-25
K-Zinc
Outmine
Ozide
Ozlo
Permanent White
Philosopher's wool
Powder base 900
Protox type 166
Protox type 167
Protox type 168
Protox type 169
Protox type 267
Protox type 268
Red Seal 9
Snow White
Unichem ZO
Vandem VAC
Vandem VOC
White seal-7
XX 203
XX 601
XX 78
Zinc oxide (ACGIH:OSHA)
Zinc oxide fume
Zinc oxide fume (OSHA)
Zinc White
Zinca 20
Zincite
Zincoid
Zn 0701T
ZN-0401 E 3/16''
Actox 16
Actox 216
AI3-00277
Akro-zinc bar 85
Akro-zinc bar 90
Amalox
Azo-33
Azo-55
Azo-55TT
Azo-66
Azo-66TT
Azo-77
Azo-77TT
Azodox-55
Azodox-55TT
C.I. 77947
C.I. Pigment White 4
Cadox XX 78
Chinese White
Cynku tlenek (Polish)
Electox 2500
Emanay zinc oxide
EMAR
Felling zinc oxide
Flowers of zinc
GIAP 10
Green seal-8
Hubbuck's White
Kadox 15
Kadox 72
Kadox-25
K-Zinc
Outmine
Ozide
Ozlo
Permanent White
Philosopher's wool
Powder base 900
Protox type 166
Protox type 167
Protox type 168
Protox type 169
Protox type 267
Protox type 268
Red Seal 9
Snow White
Unichem ZO
Vandem VAC
Vandem VOC
White seal-7
XX 203
XX 601
XX 78
Zinc oxide (ACGIH:OSHA)
Zinc oxide fume
Zinc oxide fume (OSHA)
Zinc White
Zinca 20
Zincite
Zincoid
Zn 0701T
ZN-0401 E 3/16''
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 500 mg/24H | mild | 28ZPAK -,10,1972 |
skin /rabbit | 500 mg/24H | mild | 28ZPAK -,10,1972 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | inhalation/rat | 100 µg/m3 | CYGEDX 12(3),46,1978 |
Cytogenetic Analysis | other cell types/human | 100 µmol/L/30H | MUREAV 650,39,2008 |
DNA adduct | /Escherichia coli | 3000 ppm | MUREAV 89,95,1981 |
micronucleus test | lung/human | 1.25 µg/well/48H | MUREAV 805,7,2016 |
morphological transform | embryo/hamster | 1 mg/L | SHIGAZ 74,1385,1987 |
other mutation test systems | oral/Drosophila melanogaster | 6.25 mmol/L/48H | FCTOD7 84,55,2015 |
sister chromatid exchange | embryo/hamster | 300 µg/L | SHIGAZ 74,1385,1987 |
Unscheduled DNA Synthesis | inhalation/guinea pig | 5300 µg/m3/3H/6D | TXAPA9 78,29,1985 |
Unscheduled DNA Synthesis | embryo/hamster | 1 mg/L | SHIGAZ 74,1385,1987 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | 6846 mg/kg (1-22D pregnant) | Reproductive: Specific developmental abnormalities: Homeostasis Reproductive: Effects on newborn: Stillbirth Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | JONUAI 98,303,1969 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Human, leukemia cells | Inhibitor Concentration Low: 10 mg/L/24H | In Vitro Toxicity Studies: Apoptosis in vitro | TOXRE* 3,430,2016 |
In Vitro/Human, lung | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 27,174,2013 |
In Vitro/Human, lung | Inhibitor Concentration (50 percent kill): 0.2 gm/L/24H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 27,174,2013 |
In Vitro/Human, lung | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Other assays | TIVIEQ 27,174,2013 |
In Vitro/Human, lung tumor | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 27,174,2013 |
In Vitro/Human, lung tumor | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 27,174,2013 |
In Vitro/Human, oral mucosa | Inhibitor Concentration Low: 0.31 gm/L/5M | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 30,402,2015 |
In Vitro/Human, oral mucosa | Inhibitor Concentration Low: 0.31 gm/L/5M | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 30,402,2015 |
In Vitro/Human, oral mucosa | Inhibitor Concentration Low: 1.25 gm/L/5M | In Vitro Toxicity Studies: Cell morphology: overgrowth of cell appendixes etc. | TIVIEQ 30,402,2015 |
In Vitro/Mouse, fibroblast | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 27,174,2013 |
In Vitro/Mouse, fibroblast | Inhibitor Concentration (50 percent kill): 0.1 gm/L/24H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 27,174,2013 |
In Vitro/Mouse, macrophage | Inhibitor Concentration Low: 12.13 mg/L/24H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. In Vitro Toxicity Studies: Other assays | TIVIEQ 28,1144,2014 |
In Vitro/Rat, lung | Inhibitor Concentration (50 percent kill): 977.2 µmol/L/1H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 32,347,2016 |
In Vitro/Rat, lung | Inhibitor Concentration (50 percent kill): 1230.3 µmol/L/1H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 32,347,2016 |
In Vitro/Rat, lung | Inhibitor Concentration (50 percent kill): 2630.3 µmol/L/1H | In Vitro Toxicity Studies: Cell protein synthesis | TIVIEQ 32,347,2016 |
In Vitro/Rat, lung | Inhibitor Concentration (50 percent kill): 1047.1 µmol/L/1H | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TIVIEQ 32,347,2016 |
inhalation/human | lowest published toxic concentration: 600 mg/m3 | Lung, Thorax, or Respiration: Cough Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Other changes | JIDHAN 9,88,1927 |
inhalation/mouse | lethal concentration (50 percent kill): 2500 mg/m3 | ENTOX* -,481,2005 | |
inhalation/rat | lowest published toxic concentration: 25 mg/m3/3H | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 72,298,2003 |
inhalation/rat | lowest published toxic concentration: 25 mg/m3/3H | Lung, Thorax, or Respiration: Other changes Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 44,213,2005 |
intraperitoneal/rat | lethal dose (50 percent kill): 240 mg/kg | ZDKAA8 38(9),18,1978 | |
intratracheal/mammal (species unspecified) | lowest published toxic dose: 250 mg/kg | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Other changes | VCVN1* -,151,1988 |
intratracheal/rat | Lethal dose: >4979 µg/kg | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | ESKGA2 35,P19,1989 |
oral/human | lowest published lethal dose: 500 mg/kg | YAKUD5 22,291,1980 | |
oral/mouse | lethal dose (50 percent kill): 7950 mg/kg | ENTOX* -,481,2005 | |
oral/rat | Lethal dose: >8437 mg/kg | GTPZAB 18(5),48,1974 | |
Tank with water/Daphnia | lethal concentration (50 percent kill): 5.5 mg/L/96H | AQUTO* 178,158,2016 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/guinea pig | lowest published toxic concentration: 5900 µg/m3/3H/3D- intermittent | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | JTEHD6 25,57,1988 |
inhalation/guinea pig | lowest published toxic concentration: 4600 µg/m3/3H/6D- intermittent | Lung, Thorax, or Respiration: Other changes Lung, Thorax, or Respiration: Changes in lung weight | TXAPA9 78,29,1985 |
inhalation/guinea pig | lowest published toxic concentration: 5 mg/m3/6D- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | HBTME* -,925,2007 |
inhalation/mammal (species unspecified) | lowest published toxic concentration: 15 mg/m3/1H/84D- intermittent | Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Other changes | VCVN1* -,153,1988 |
inhalation/rat | lowest published toxic concentration: 6.9 mg/m3/7D- intermittent | Lung, Thorax, or Respiration: Other changes Lung, Thorax, or Respiration: Changes in lung weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | INHTE5 15,435,2003 |
oral/chicken | lowest published toxic dose: 6468 mg/kg/1W- intermittent | Endocrine: Evidence of thyroid hypofunction Blood: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TOLED5 57,309,1991 |
oral/chicken | lowest published toxic dose: 12.93 gm/kg/2W- intermittent | Endocrine: Change in GH | TOLED5 57,309,1991 |
oral/chicken | lowest published toxic dose: 25.87 gm/kg/4W- intermittent | Endocrine: Other changes | TOLED5 57,309,1991 |
oral/chicken | lowest published toxic dose: 32203 mg/kg/4W- continuous | Endocrine: Change in GH Endocrine: Evidence of thyroid hypofunction Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TOLED5 57,309,1991 |
oral/domestic animal | lowest published toxic dose: 3584 mg/kg/4W- intermittent | Gastrointestinal: Changes in structure or function of exocrine pancreas Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Changes in: Other metals | JJATDK 4,92,1984 |
oral/rat | lowest published toxic dose: 17431 mg/kg/90D- continuous | Behavioral: Change in motor activity (specific assay) | TOXID9 36(1 Pt2),183,1997 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 2 mg/m3;short term exposure limit 10 mg/m3 (resp) | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | ANAEA3 35,165,1975 | |
TOXICOLOGY REVIEW | JIDHAN 8,322,1926 | |
TOXICOLOGY REVIEW | ENTOX* -,481,2005 | |
TOXICOLOGY REVIEW | HBTME* ,925,2007 | |
TOXICOLOGY REVIEW | HUTOX* -,661,1996 | |
TOXICOLOGY REVIEW | HUTOX* -,515,1996 | |
TOXICOLOGY REVIEW | NBREV* 5,1,1981 | |
TOXICOLOGY REVIEW | TXAPA9 243,239,2010 | |
TOXICOLOGY REVIEW | MUREAV 727,72,2011 | |
TOXICOLOGY REVIEW | MUREAV 752,67,2013 | |
TOXICOLOGY REVIEW | MUTAEX 30,67,2015 | |
TOXICOLOGY REVIEW | FCTOD7 91,42,2016 | |
TOXICOLOGY REVIEW | MUTAEX 32,203,2017 | |
TOXICOLOGY REVIEW | MUREAV 770,204,2016 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION | FEREAC 54,7740,1989 | |
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF PESTICIDES | RED Completed | RBREV* -,346,1998 |
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 5 mg/m3 (fume) | DTLVS* 3,284,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 5 mg/m3, JAN1993 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 10 mg/m3 (dust), JUL2008 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 5 mg/m3, short term exposure limit 10 mg/m3 (fume), JUL2008 | |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 5 mg/m3, resp, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 10 mg/m3 (dust), MAR2002 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 5 mg/m3, short term exposure limit 10 mg/m3 (fume), MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 4 mg(Zn)/m3 (fume), MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 2 mg/m3, short term exposure limit 10 mg/m3, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 10 mg/m3 (dust), 5 mg/m3 (fume), FEB2006 | |
Occupational Exposure Limit-GERMANY | MAK 0.1 mg(Zn)/m3, resp, 2011 | |
Occupational Exposure Limit-GERMANY | MAK 2 mg(Zn)/m3, inhal, 2011 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 5 mg/m3 (resp), short term exposure limit 20 mg/m3 (resp), SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 4 mg(Zn)/m3, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 1 mg/m3 (resp. dust), 4 mg/m3 (total dust), MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 10 mg/m3, 2006 | |
Occupational Exposure Limit-KOREA | time-weighted average 5 mg/m3, short term exposure limit 10 mg/m3, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 5 mg/m3 (fume), 2004 | |
Occupational Exposure Limit-MEXICO | time-weighted average 10 mg/m3;short term exposure limit 10 mg/m3 (inhalable), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 5 mg/m3 (fume), short term exposure limit 10 ppm (fume), JAN2002 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 10 mg/m3 (inspirable dust), JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 5 mg/m3, JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 2 mg/m3; short term exposure limit 10 mg/m3, JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) fume 5 mg/m3, MAC(short term exposure limit) fume 10 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | time-weighted average 0.5 mg/m3, short term exposure limit 1.5 mg/m3, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 5 mg/m3, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | ceiling concentration 0.125 mg/m3, fume, JAN2011 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.1 mg(Zn)/m3, KZG-week 0.4 mg(Zn)/m3, resp, JAN2011 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 2 mg(Zn)/m3, KZG-week 4 mg(Zn)/m3, inhal, JAN2011 | |
Occupational Exposure Limit-THAILAND | time-weighted average 5 mg/m3 (fume), JAN1993 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 5 mg/m3, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 1 mg/m3, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 5 mg/m3, JAN1993 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 5 mg/m3, fume and respirable fraction | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 15 mg/m3, total dust | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 5 mg/m3 | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 5 mg/m3, fume and respirable fraction | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 15 mg/m3, total dust | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 5 mg/m3, fume and respirable fraction | CFRGBR 29,1915.1000,1993 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 15 mg/m3, total dust | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ZINC OXIDE, fume-air | 10H time-weighted average 5 mg/m3;short term exposure limit 10 mg/m3 | NIOSH* DHHS #92-100,1992 |
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ZINC OXIDE, total dust-air | time-weighted average 5 mg/m3;ceiling concentration 15 mg/m3/15M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code X5686; Number of Industries 295; Total Number of Facilities 56635; Number of Occupations 168; Total Number of Employees Exposed 919197; Total Number of Female Employees Exposed 151582 | |
National Occupational Exposure Survey 1983 | Hazard Code X9509; Number of Industries 1; Total Number of Facilities 7; Number of Occupations 1; Total Number of Employees Exposed 105; Total Number of Female Employees Exposed 7 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health